Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Learn how to effectively engage in virtual networking for financial planners to expand your reach and connect with industry experts.
16,067 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
STRC slid to a deep intraday low near $82.61 on June 18 before rebounding, signaling distress in the Bitcoin-linked d...
New to crypto? This beginner-friendly guide walks you through the top cryptocurrencies for beginners, how to evaluate...
Marques Colston and Nick Edwards unveil the Champion Fund, inviting fans to invest in sports with a $500 entry. The p...
A newCapital Economics note warns that the current rotation in U.S. equities could be a forerunner to a broader corre...
A new wave in energy investing centers on nuclear power having moment. This article identifies three stocks that stan...
Federal Reserve officials weighed the strength of the labor market as January payrolls edge higher, creating a tense ...
Which S&P 500 ETF is the better etf for you? This guide compares VOO and SPY on costs, liquidity, and tracking, with ...
A major biotech setback on Feb. 23 spooked investors and nudged major indices lower. This piece breaks down what happ...
As AI pushes data growth, memory stocks grab the spotlight. This guide explains why don’t forget about western—Wester...
A rising AI-driven marketing platform secures a NASDAQ ticker and raises over $50 million, signaling a new wave of in...
One hidden nuclear-energy stock connected to the space economy could be a game changer. This article explains how it ...